PW Medtech Group Limited (01358) issued a Next Day Disclosure Return on 06 February 2026, confirming no changes to its total issued share capital of 1,473,589,098 ordinary shares as of the closing date. The disclosure reveals that multiple share repurchases have been executed but are not yet canceled, spanning from 23 September 2025 through 06 February 2026. These transactions occurred at various prices, with the highest reported repurchase price of HKD 1.555 on 26 September 2025.

On 06 February 2026, the company repurchased 410,000 shares on the Exchange, at prices ranging from HKD 1.31 to HKD 1.32, for an aggregate consideration of HKD 540,510. The cumulative number of shares repurchased under a mandate granted on 10 June 2025 is 17,668,000 shares, representing approximately 1.1884% of PW Medtech’s issued share capital at the time of the mandate. According to the announcement, a moratorium period on new share issuance or transfer of treasury shares extends until 08 March 2026.